CHARACTERISTICS
ACTIVE HALF-LIFE 1 DAY
CLASSIFICATION THYROID HORMONE
DOSAGE 25-75 MCG/DAY
ACNE NO
WATER RETENTION NO
HBR YES
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE LIOTHYRONINE SODIUM
FORM 100 TABLETS X 25 MCG
MANUFACTURER ABDI IBRAHIM
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma
MANUFACTURER: GlaxoSmithKline
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
It is used for the management of chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by breathing difficulties, coughing, and wheezing. This medication is designed to provide comprehensive treatment for COPD by addressing various aspects of the disease.
DISEASE INDICATIONS: Psoriasis
MANUFACTURER: Janssen Biotech
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Therapeutic Goods Administration (TGA)
Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.
